| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.60B | +13.7% |
| Cost of Revenue | $498.2M | +12.8% |
| Gross Profit | $1.10B | +14.2% |
| R&D Expense | $205.9M | +15.4% |
| SG&A Expense | $212.9M | +13.6% |
| Operating Income | $304.0M | +16.9% |
| Pre-tax Income | $309.1M | +11.6% |
| Income Tax | $81.9M | +16.6% |
| Net Income | $227.1M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $398.1M | -0.9% |
| Accounts Receivable | $41.6M | +26.2% |
| Current Assets | $3.31B | -6.0% |
| Total Assets | $4.39B | +3.4% |
| Current Liabilities | $2.91B | -6.8% |
| Long-term Debt | $162.5M | — |
| Total Liabilities | $3.16B | -1.8% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $418.2M | +8.7% |
| Capital Expenditures | $13.1M | -27.5% |
| Investing Cash Flow | -$455.5M | -347.1% |
| Financing Cash Flow | -$325.8M | -330.1% |
| Free Cash Flow | $405.2M | +10.5% |
| +9.8% |
| EPS (Basic) | $4.08 | +10.9% |
| EPS (Diluted) | $4.02 | +10.7% |
| Stockholders' Equity |
| $1.23B |
| +19.4% |